Albertini M, Lazartigues D, Politano S, Bourrier T, Mariani R
Clinique Médicale Infantile, Hôpital de Cimiez, Nice.
Rev Mal Respir. 1992;9(3):269-76.
During the last fifteen years, inhaled corticosteroids were increasingly used for prophylaxis in childhood asthma. The development of inhaled corticosteroids with a high ratio of topical vs systemic potency, now makes possible their use in large doses which are needed to control the most severe forms of the disease, in order to avoid long term oral corticosteroid treatment for these patients. The efficacy of inhaled corticosteroids depends on an optimal pulmonary deposition of the drug which is obtained with children by inhaling the drug via a large volume spacer. Beyond their beneficial effects on the clinical condition of the patients and on pulmonary function, inhaled corticosteroids should improve the long term prognosis of asthma, by reducing chronic inflammation in the airways and the associated bronchial hyperreactivity. At usual dosages, inhaled corticosteroids are free of harmful side effects. However, caution and close observation of adrenal function and growth development are required when prescribing inhaled corticosteroids at high dosages for a long period. Nevertheless, inhaled corticosteroids present very few serious side effects compared with those induced by long term oral corticosteroid treatment.
在过去的十五年中,吸入性糖皮质激素越来越多地用于儿童哮喘的预防。目前,具有高局部与全身效力比的吸入性糖皮质激素的开发,使得能够使用控制该疾病最严重形式所需的大剂量药物,从而避免对这些患者进行长期口服糖皮质激素治疗。吸入性糖皮质激素的疗效取决于药物在肺部的最佳沉积,这通过让儿童经大容量储雾罐吸入药物来实现。除了对患者临床状况和肺功能有有益作用外,吸入性糖皮质激素还应通过减轻气道慢性炎症和相关的支气管高反应性来改善哮喘的长期预后。在常用剂量下,吸入性糖皮质激素没有有害副作用。然而,长期高剂量开具吸入性糖皮质激素处方时,需要谨慎并密切观察肾上腺功能和生长发育情况。尽管如此,与长期口服糖皮质激素治疗引起的副作用相比,吸入性糖皮质激素的严重副作用非常少。